What is the initial dosing strategy used in clinical trials for new drugs, and why is this approach important?

In clinical trials, new drugs begin with very low doses to assess safety before increasing to the optimum dose. This approach is important because it minimizes the risk of adverse effects and allows researchers to monitor how the body responds to the drug at lower levels.

This answer is strong because it clearly states the initial dosing strategy and its significance in ensuring patient safety during drug trials. The question tests the understanding of clinical trial protocols and the rationale behind them.